Skip to main content
34°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Fresenius Kabi
< Previous
1
2
Next >
Fresenius Kabi Broadens Radiology Portfolio with its First-to-Market Authorized Generic, Sincalide for Injection
June 21, 2023
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Launches Vasopressin Injection, USP Expanding U.S. Critical Care Portfolio
June 14, 2023
From
Fresenius Kabi
Via
Business Wire
Supporting Patient Safety: Fresenius Kabi Expands Ready-to-Administer Portfolio with Diazepam Injection, USP in Simplist® Prefilled Syringe
May 31, 2023
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection, its First Product Compatible with Bluesight's KitCheck System
May 30, 2023
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Awarded Technology Breakthrough Agreement with Premier, Inc. for the Ivenix Infusion System
May 23, 2023
From
Fresenius Kabi
Via
Business Wire
CMS grants Fresenius Kabi permanent, product-specific Q-Code for Stimufend® (pegfilgrastim-fpgk)
May 16, 2023
From
Fresenius Kabi
Via
Business Wire
Vizient Innovative Technology Contract Awarded to Fresenius Kabi for the Ivenix Infusion System
April 17, 2023
From
Fresenius Kabi
Via
Business Wire
Stimufend® (pegfilgrastim-fpgk) Now Available in the United States
February 16, 2023
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi’s Ivenix Infusion System Goes Live at San Luis Valley Health
January 10, 2023
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Targets Treatment of Certain Seizures with Launch of Generic Lacosamide Injection, USP
December 15, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Introduces Pralatrexate Injection for the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
December 08, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Introduces KabiCare Nutrition Resources for U.S. Parenteral Nutrition Products
December 05, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Announces 2022 Inductees to Blood Donation Hall of Fame
November 09, 2022
From
Fresenius Kabi
Via
Business Wire
Fort HealthCare Goes Live with Smart Pump Interoperability with the Ivenix Infusion System from Fresenius Kabi
October 11, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Named 2022 Pharmaceutical Supplier Partner of the Year by Vizient
October 06, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Expands Contrast Agent Portfolio with Launch of Gadoterate Meglumine Injection, USP
October 04, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Selected to Exhibit the Ivenix Infusion System at Vizient Innovative Technology Exchange
September 13, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend® (pegfilgrastim - fpgk)
September 06, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi and AABB Celebrate 17th Annual Blood Collectors Week from September 4-10, 2022
September 04, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi, a Leader in Injectable Medicines, Introduces Data Matrix Barcodes on all Drugs as part of Companywide Commitment to Medication Safety
August 08, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
July 29, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Injection, USP Simplist® Prefilled Syringe
July 25, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent
July 18, 2022
From
Fresenius Kabi
Via
Business Wire
Romidepsin for Injection Available from Fresenius Kabi
July 12, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Expands RFID Compatibility to Improve Hospital Inventory Management
June 14, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer
May 31, 2022
From
Fresenius Kabi
Via
Business Wire
Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America
May 18, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma
May 02, 2022
From
Fresenius Kabi
Via
Business Wire
Fresenius Kabi Introduces Calcium Gluconate in Sodium Chloride Injection in Ready-to-Administer freeflex® Bags
April 27, 2022
From
Fresenius Kabi
Via
Business Wire
Blood Centers Across America Unite to Provide Blood Supplies to Ukraine
April 18, 2022
From
Fresenius Kabi
Via
Business Wire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.